21-01-2026 14:00 via wallstreet-online.de

Ensysce Biosciences Expands Global Opioid Patent Portfolio

~ TAAP™ and MPAR® technologies extended across opioid products to advance safer pain treatment ~ SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 21, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a …
Weiterlesen »